| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | ZNF609 CBX3 CHD2 MED1 SAFB ZNF276 TTC21B KMT2A ANKRD17 MLLT1 MLLT3 NKX6-1 CABIN1 NIPBL TOP2A | 6.49e-06 | 739 | 104 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA clamp unloader activity | 2.69e-05 | 2 | 104 | 2 | GO:0061860 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.86e-05 | 262 | 104 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.02e-04 | 206 | 104 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 5.03e-04 | 30 | 104 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 5.35e-04 | 127 | 104 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 5.55e-04 | 31 | 104 | 3 | GO:0140033 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.36e-05 | 158 | 102 | 7 | GO:0050684 | |
| GeneOntologyBiologicalProcess | DNA clamp unloading | 2.42e-05 | 2 | 102 | 2 | GO:0090618 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | LUC7L3 SYNE1 HMGXB4 CBX3 UPF3B NUP58 MED1 DRAP1 RNPS1 CEBPZ FANCI MED12L HTATSF1 KMT2A MLLT1 AFF1 MLLT3 NIPBL THRAP3 AFF4 | 1.48e-05 | 1377 | 105 | 20 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear speck | LUC7L3 ZC3H13 RREB1 YTHDC1 PPIG RNPS1 FAM76A ZNF638 ARHGAP18 THRAP3 | 6.30e-05 | 431 | 105 | 10 | GO:0016607 |
| GeneOntologyCellularComponent | Elg1 RFC-like complex | 7.47e-05 | 3 | 105 | 2 | GO:0031391 | |
| GeneOntologyCellularComponent | AP-type membrane coat adaptor complex | 9.87e-05 | 48 | 105 | 4 | GO:0030119 | |
| GeneOntologyCellularComponent | exon-exon junction complex | 1.53e-04 | 21 | 105 | 3 | GO:0035145 | |
| GeneOntologyCellularComponent | nuclear body | LUC7L3 CENPC ZC3H13 OBSCN RREB1 YTHDC1 PPIG RNPS1 FAM76A SLTM ZNF638 ELF4 ARHGAP18 THRAP3 | 1.69e-04 | 903 | 105 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | transcription elongation factor complex | 1.81e-04 | 56 | 105 | 4 | GO:0008023 | |
| GeneOntologyCellularComponent | super elongation complex | 3.70e-04 | 6 | 105 | 2 | GO:0032783 | |
| GeneOntologyCellularComponent | myofilament | 5.49e-04 | 32 | 105 | 3 | GO:0036379 | |
| GeneOntologyCellularComponent | mediator complex | 8.45e-04 | 37 | 105 | 3 | GO:0016592 | |
| GeneOntologyCellularComponent | AP-3 adaptor complex | 1.88e-03 | 13 | 105 | 2 | GO:0030123 | |
| GeneOntologyCellularComponent | membrane coat | 2.02e-03 | 106 | 105 | 4 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 2.02e-03 | 106 | 105 | 4 | GO:0048475 | |
| GeneOntologyCellularComponent | motile cilium | 2.11e-03 | 355 | 105 | 7 | GO:0031514 | |
| Domain | AP3_beta | 3.31e-05 | 2 | 108 | 2 | IPR026740 | |
| Domain | AP3B_C | 3.31e-05 | 2 | 108 | 2 | IPR029390 | |
| Domain | AP3B1_C | 3.31e-05 | 2 | 108 | 2 | PF14796 | |
| Domain | AP3B1_C | 3.31e-05 | 2 | 108 | 2 | SM01355 | |
| Domain | Clathrin/coatomer_adapt-like_N | 8.13e-05 | 15 | 108 | 3 | IPR002553 | |
| Domain | Adaptin_N | 8.13e-05 | 15 | 108 | 3 | PF01602 | |
| Domain | YEATS | 1.97e-04 | 4 | 108 | 2 | IPR005033 | |
| Domain | YEATS | 1.97e-04 | 4 | 108 | 2 | PS51037 | |
| Domain | TF_AF4/FMR2 | 1.97e-04 | 4 | 108 | 2 | IPR007797 | |
| Domain | AF-4 | 1.97e-04 | 4 | 108 | 2 | PF05110 | |
| Domain | YEATS | 1.97e-04 | 4 | 108 | 2 | PF03366 | |
| Domain | AP_beta | 3.28e-04 | 5 | 108 | 2 | IPR026739 | |
| Domain | - | 5.42e-04 | 244 | 108 | 7 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 7.54e-04 | 258 | 108 | 7 | IPR012677 | |
| Domain | RRM_1 | 1.32e-03 | 208 | 108 | 6 | PF00076 | |
| Domain | RRM | 1.64e-03 | 217 | 108 | 6 | SM00360 | |
| Domain | RRM_dom | 2.06e-03 | 227 | 108 | 6 | IPR000504 | |
| Domain | Znf_C2H2_matrin | 2.11e-03 | 12 | 108 | 2 | IPR000690 | |
| Domain | RRM | 2.20e-03 | 230 | 108 | 6 | PS50102 | |
| Domain | PIN_domain-like | 2.88e-03 | 14 | 108 | 2 | IPR029060 | |
| Domain | Chromodomain_CS | 4.77e-03 | 18 | 108 | 2 | IPR023779 | |
| Domain | ZF_MATRIN | 4.77e-03 | 18 | 108 | 2 | PS50171 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 1.07e-05 | 26 | 76 | 4 | M47439 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF609 MAP1B LUC7L3 CENPC ATAD5 EML4 ZC3H13 KTN1 HMGXB4 CBX3 SRP14 RFC1 MED1 RREB1 SAFB CEBPZ PA2G4 FANCI SLTM ZNF638 PDCD11 HTATSF1 KMT2A MLLT1 NIPBL THRAP3 TOP2A AFF4 NSMCE1 ILKAP | 5.17e-22 | 954 | 108 | 30 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF609 ATXN7L2 TFAP2D LUC7L3 ATAD5 ZC3H13 KTN1 HMGXB4 CBX3 SRP14 CHD2 RFC1 MED1 RREB1 YTHDC1 ESCO1 PPIG SAFB ZNF276 RNPS1 CEBPZ SLTM ZNF638 PDCD11 HTATSF1 KMT2A MLLT1 ELF4 MRGBP CABIN1 NIPBL THRAP3 TOP2A | 1.90e-21 | 1294 | 108 | 33 | 30804502 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | CENPC ATAD5 HMGXB4 CBX3 CHD2 RFC1 MED1 RREB1 FSIP2 PHF20L1 RNPS1 FANCI KMT2A MRGBP CABIN1 NIPBL TOP2A AFF4 NSMCE1 ILKAP | 3.67e-15 | 608 | 108 | 20 | 36089195 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP1B FLYWCH2 ATAD5 KTN1 NACA CBX3 UPF3B RFC1 MED1 SAFB RNPS1 PA2G4 ZNF638 HTATSF1 KMT2A ANKRD17 DLD NIPBL ARHGAP21 TOP2A AFF4 PCNT ILKAP | 1.19e-14 | 934 | 108 | 23 | 33916271 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RARS1 MAP1B CENPC EML4 KTN1 NACA CBX3 SRP14 CHD2 RFC1 MYEF2 WDR47 RAB3GAP1 SAFB FAM120A RNPS1 CEBPZ PA2G4 FANCI SLTM ZNF638 PDCD11 ANKRD17 NIPBL THRAP3 TOP2A | 5.57e-14 | 1353 | 108 | 26 | 29467282 |
| Pubmed | RARS1 LUC7L3 EML4 KTN1 NACA DAB1 CBX3 SRP14 CHD2 UPF3B RFC1 MED1 AP3B1 PPIG FAM120A RNPS1 CEBPZ PA2G4 TCHHL1 PDCD11 KMT2A ANKRD17 MRGBP PAK1IP1 THRAP3 AFF4 | 7.55e-14 | 1371 | 108 | 26 | 36244648 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RARS1 LUC7L3 ZC3H13 NACA CBX3 SRP14 CHD2 RFC1 RREB1 AP3B1 YTHDC1 PPIG SAFB FAM120A RNPS1 CEBPZ PA2G4 PDCD11 KMT2A DLD PAK1IP1 NIPBL THRAP3 TOP2A | 1.91e-12 | 1318 | 108 | 24 | 30463901 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EML4 ZC3H13 RFC1 MED1 RREB1 YTHDC1 USP19 OTUD7B PPIG SAFB RNPS1 ZNF638 KMT2A ANKRD17 AFF1 PAK1IP1 NIPBL THRAP3 TOP2A | 3.32e-12 | 774 | 108 | 19 | 15302935 |
| Pubmed | ZNF609 RARS1 KTN1 AGR2 CBX3 UPF3B RFC1 MED1 AP3B1 YTHDC1 PPIG FAM120A RNPS1 CEBPZ PA2G4 ANKRD17 MLLT1 DLD AFF1 MLLT3 THRAP3 TOP2A AFF4 | 4.61e-12 | 1247 | 108 | 23 | 27684187 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | LUC7L3 SYNE1 ZC3H13 SRP14 CHD2 UPF3B YTHDC1 MYEF2 PPIG SAFB FAM120A RNPS1 CEBPZ SLTM ZNF638 PDCD11 THRAP3 TOP2A NOVA1 | 6.82e-12 | 807 | 108 | 19 | 22681889 |
| Pubmed | LUC7L3 ZC3H13 SRP14 UPF3B RFC1 YTHDC1 MYEF2 PPIG SAFB FAM120A RNPS1 FANCI SLTM ZNF638 HTATSF1 PAK1IP1 THRAP3 TOP2A | 8.26e-12 | 713 | 108 | 18 | 29802200 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RARS1 LUC7L3 SYNE1 KTN1 NACA CBX3 SRP14 UPF3B RFC1 AP3B1 USP19 SAFB FAM120A RNPS1 CEBPZ PA2G4 FANCI SLTM PDCD11 DLD PAK1IP1 NIPBL THRAP3 TOP2A | 9.79e-12 | 1425 | 108 | 24 | 30948266 |
| Pubmed | LUC7L3 ZC3H13 KTN1 CBX3 SRP14 RFC1 YTHDC1 SAFB FAM120A RNPS1 CEBPZ SLTM ZNF638 PDCD11 KMT2A ANKRD17 PAK1IP1 THRAP3 TOP2A | 1.56e-11 | 847 | 108 | 19 | 35850772 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ZNF536 MAP1B KTN1 HMGXB4 REV3L DRAP1 YTHDC1 MYEF2 WDR47 FAM120A PHF20L1 PA2G4 ANKRD17 MRGBP NKX6-1 CABIN1 THRAP3 TOP2A NOVA1 | 1.91e-11 | 857 | 108 | 19 | 25609649 |
| Pubmed | MAP1B ZC3H13 CBX3 CHD2 RFC1 MYEF2 FAM120A CEBPZ FANCI SLTM ZNF638 PDCD11 KMT2A ANKRD17 DLD NIPBL PCNT | 2.06e-11 | 653 | 108 | 17 | 22586326 | |
| Pubmed | CENPC ATAD5 CBX3 SRP14 CHD2 RFC1 MED1 YTHDC1 PPIG SAFB PA2G4 FANCI SLTM HTATSF1 KMT2A PAK1IP1 NIPBL THRAP3 TOP2A ILKAP | 4.26e-11 | 1014 | 108 | 20 | 32416067 | |
| Pubmed | CENPC RFC1 YTHDC1 CEBPZ ZNF638 HTATSF1 KMT2A NIPBL THRAP3 TOP2A PCNT | 6.18e-11 | 210 | 108 | 11 | 16565220 | |
| Pubmed | 6.55e-11 | 10 | 108 | 5 | 20153263 | ||
| Pubmed | Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4. | 8.79e-11 | 4 | 108 | 4 | 25282333 | |
| Pubmed | RARS1 LUC7L3 ZC3H13 NACA SRP14 MYEF2 PPIG SAFB RNPS1 CEBPZ PA2G4 SLTM PDCD11 PAK1IP1 THRAP3 TOP2A NSMCE1 | 1.18e-10 | 731 | 108 | 17 | 29298432 | |
| Pubmed | MAP1B CENPC FLYWCH2 ATAD5 UPF3B RFC1 MED1 MESD RNPS1 SLTM ZNF638 KMT2A MRGBP CABIN1 THRAP3 PCNT | 1.71e-10 | 645 | 108 | 16 | 25281560 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RARS1 MAP1B LUC7L3 SYNE1 NACA CBX3 NUP58 MYEF2 SAFB RNPS1 CEBPZ PA2G4 SLTM ZNF638 PDCD11 NIPBL THRAP3 TOP2A PCNT | 3.85e-10 | 1024 | 108 | 19 | 24711643 |
| Pubmed | LUC7L3 ZC3H13 CBX3 PPIG SAFB FAM120A ZNF638 KMT2A THRAP3 TOP2A PCNT | 4.14e-10 | 251 | 108 | 11 | 31076518 | |
| Pubmed | 5.15e-10 | 14 | 108 | 5 | 20854876 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RARS1 EML4 ZC3H13 KTN1 CBX3 SRP14 MED1 RAB11FIP1 YTHDC1 MYEF2 SAFB FAM120A PA2G4 SLTM ZNF638 TOP2A | 5.72e-10 | 701 | 108 | 16 | 30196744 |
| Pubmed | ZC3H13 CBX3 RFC1 MED1 RAB11FIP1 YTHDC1 SAFB FAM120A PA2G4 FANCI ZNF638 NIPBL THRAP3 TOP2A | 5.92e-10 | 503 | 108 | 14 | 16964243 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MAP1B LUC7L3 SYNE1 ZC3H13 HMGXB4 CBX3 SRP14 CHD2 MED1 YTHDC1 MYEF2 PPIG SAFB SLTM ZNF638 PAK1IP1 NIPBL THRAP3 AFF4 | 9.57e-10 | 1082 | 108 | 19 | 38697112 |
| Pubmed | TFAP2D RARS1 ATAD5 SYNE1 KTN1 NACA HMGXB4 CHD2 MED1 RAB11FIP1 AP3B1 YTHDC1 MYEF2 CEBPZ PA2G4 PDCD11 KMT2A ANKRD17 MLLT1 PAK1IP1 NIPBL AFF4 | 1.06e-09 | 1497 | 108 | 22 | 31527615 | |
| Pubmed | ZNF536 ZNF609 ATXN7L2 ATAD5 HMGXB4 CBX3 SRP14 REV3L RAB11FIP1 RREB1 MYEF2 FAM120A RNPS1 ANKRD17 MLLT1 MRGBP TOP2A AFF4 NSMCE1 | 1.59e-09 | 1116 | 108 | 19 | 31753913 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RARS1 LUC7L3 CENPC CBX3 SRP14 RFC1 YTHDC1 SAFB CEBPZ FANCI SLTM ZNF638 PDCD11 MRGBP PAK1IP1 THRAP3 TOP2A AFF4 | 1.59e-09 | 989 | 108 | 18 | 36424410 |
| Pubmed | MAP1B CENPC SYNE1 KTN1 CBX3 SRP14 CHD2 SAFB PHF20L1 RNPS1 CEBPZ TCHHL1 KMT2A MLLT1 DLD DLG2 NIPBL THRAP3 ARHGAP21 TOP2A PCNT | 3.16e-09 | 1442 | 108 | 21 | 35575683 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | LUC7L3 ATAD5 ZC3H13 CBX3 RFC1 SAFB FAM120A CEBPZ ZNF638 PDCD11 HTATSF1 KMT2A THRAP3 TOP2A | 6.24e-09 | 605 | 108 | 14 | 28977666 |
| Pubmed | ZNF536 ATAD5 KTN1 CHD2 REV3L RFC1 MED1 AP3B1 TMEM200A MYEF2 RAB3GAP1 ANKRD17 LMOD1 NIPBL | 1.22e-08 | 638 | 108 | 14 | 31182584 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MAP1B ATAD5 KTN1 NACA UPF3B RFC1 MED1 FAM120A RNPS1 CEBPZ PA2G4 PDCD11 DLD PAK1IP1 TOP2A | 1.41e-08 | 759 | 108 | 15 | 35915203 |
| Pubmed | ZNF536 ZNF609 ATXN7L2 RARS1 ATAD5 NACA HMGXB4 RFC1 RREB1 FAM120A ZNF638 PDCD11 KMT2A ANKRD17 MLLT1 DLD ELF4 MRGBP CABIN1 NIPBL | 1.54e-08 | 1429 | 108 | 20 | 35140242 | |
| Pubmed | 1.56e-08 | 203 | 108 | 9 | 35012549 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.18e-08 | 148 | 108 | 8 | 32538781 | |
| Pubmed | CHD2 UPF3B RFC1 YTHDC1 FAM120A CEBPZ FANCI SLTM ZNF638 HTATSF1 KMT2A TOP2A | 2.72e-08 | 469 | 108 | 12 | 27634302 | |
| Pubmed | 2.85e-08 | 11 | 108 | 4 | 20471949 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 16433901 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 10588740 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | LUC7L3 CHD2 MED1 DRAP1 YTHDC1 PPIG RNPS1 PDCD11 MLLT1 AFF1 MLLT3 THRAP3 AFF4 NOVA1 | 3.53e-08 | 695 | 108 | 14 | 23602568 |
| Pubmed | The little elongation complex regulates small nuclear RNA transcription. | 4.27e-08 | 12 | 108 | 4 | 22195968 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | MAP1B ATAD5 CBX3 CHD2 RFC1 MED1 AP3B1 ZNF638 PDCD11 KMT2A TOP2A | 4.43e-08 | 394 | 108 | 11 | 27248496 |
| Pubmed | SGIP1 SYNE1 KTN1 CBX3 ARHGEF18 MYEF2 WDR47 FAM120A ANKRD17 DLG2 CABIN1 NIPBL THRAP3 ARHGAP21 AFF4 PCNT | 4.97e-08 | 963 | 108 | 16 | 28671696 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RARS1 ZC3H13 NACA SRP14 UPF3B DRAP1 AP3B1 TMEM200A PA2G4 AP3B2 ANKRD17 DLD NIPBL THRAP3 PCNT | 5.95e-08 | 847 | 108 | 15 | 35235311 |
| Pubmed | The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically. | 6.09e-08 | 66 | 108 | 6 | 32051553 | |
| Pubmed | Transcriptional and posttranscriptional regulation of HIV-1 gene expression. | 6.15e-08 | 13 | 108 | 4 | 22355797 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RARS1 ZC3H13 NACA CBX3 RFC1 YTHDC1 SAFB FAM120A RNPS1 CEBPZ PA2G4 SLTM ZNF638 PDCD11 ANKRD17 PAK1IP1 THRAP3 TOP2A | 6.30e-08 | 1257 | 108 | 18 | 36526897 |
| Pubmed | RARS1 LUC7L3 KTN1 NACA SRP14 RFC1 SAFB FAM120A PA2G4 ZNF638 ANKRD17 THRAP3 TOP2A | 6.47e-08 | 615 | 108 | 13 | 31048545 | |
| Pubmed | LUC7L3 SRP14 YTHDC1 MYEF2 SAFB FAM120A HTATSF1 ANKRD17 TOP2A | 9.67e-08 | 251 | 108 | 9 | 28077445 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | CENPC ATAD5 HMGXB4 CBX3 CHD2 RFC1 MED1 AP3B1 KMT2A MRGBP NIPBL TOP2A | 1.09e-07 | 533 | 108 | 12 | 30554943 |
| Pubmed | Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing. | 1.16e-07 | 4 | 108 | 3 | 17581865 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 16096649 | ||
| Pubmed | ATAD5 NACA CBX3 SRP14 RAB11FIP1 SAFB CEBPZ FANCI SLTM ZNF638 NIPBL THRAP3 TOP2A | 1.27e-07 | 652 | 108 | 13 | 31180492 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | MAP1B RREB1 SAFB FAM120A CEBPZ SLTM PDCD11 HTATSF1 PAK1IP1 CABIN1 | 1.48e-07 | 349 | 108 | 10 | 25665578 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BEST1 ZNF609 MAP1B LUC7L3 OBSCN DAB1 ARHGEF18 CHD2 ZNF385B ESCO1 DNAH14 FAM120A TTC21B ZNF638 ANKRD17 AFF1 THRAP3 AFF4 PCNT | 1.56e-07 | 1489 | 108 | 19 | 28611215 |
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 1.80e-07 | 41 | 108 | 5 | 20431927 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RARS1 SYNE1 KTN1 AGR2 MUC19 CBX3 AP3B1 TMEM200A MYEF2 SAFB SLTM KMT2A DLD ARHGAP18 | 2.19e-07 | 807 | 108 | 14 | 30575818 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RARS1 LUC7L3 SYNE1 NACA SRP14 UPF3B YTHDC1 SAFB FAM120A CEBPZ SLTM PDCD11 PAK1IP1 THRAP3 TOP2A | 2.56e-07 | 949 | 108 | 15 | 36574265 |
| Pubmed | 2.60e-07 | 18 | 108 | 4 | 21030982 | ||
| Pubmed | 2.99e-07 | 86 | 108 | 6 | 37253089 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MAP1B CBX3 AP3B1 RAB3GAP1 CEBPZ PA2G4 PDCD11 HTATSF1 ANKRD17 PAK1IP1 NIPBL TOP2A ILKAP | 3.03e-07 | 704 | 108 | 13 | 29955894 |
| Pubmed | ZNF609 RARS1 FLYWCH2 SRP14 UPF3B RFC1 MED1 RREB1 SAFB FAM120A PA2G4 FANCI KMT2A NIPBL THRAP3 TOP2A | 3.11e-07 | 1103 | 108 | 16 | 34189442 | |
| Pubmed | Lost in transcription: molecular mechanisms that control HIV latency. | 3.29e-07 | 19 | 108 | 4 | 23518577 | |
| Pubmed | RARS1 SRP14 UPF3B RFC1 MYEF2 CEBPZ ZNF638 PDCD11 PAK1IP1 ARHGAP21 TOP2A | 3.40e-07 | 483 | 108 | 11 | 36912080 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RARS1 LUC7L3 FLYWCH2 EML4 KTN1 NACA CBX3 SRP14 UPF3B RFC1 AP3B1 CEBPZ PA2G4 ZNF638 HTATSF1 NIPBL THRAP3 TOP2A | 3.61e-07 | 1415 | 108 | 18 | 28515276 |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 21896721 | ||
| Pubmed | 6.09e-07 | 156 | 108 | 7 | 37108203 | ||
| Pubmed | The Role of RNA Polymerase II Elongation Control in HIV-1 Gene Expression, Replication, and Latency. | 6.16e-07 | 22 | 108 | 4 | 22567366 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 6.59e-07 | 411 | 108 | 10 | 35182466 | |
| Pubmed | CENPC ATAD5 SYNE1 ZC3H13 KTN1 SRP14 TRAPPC8 RAB11FIP1 AP3B1 USP31 RAB3GAP1 FAM120A CEBPZ PA2G4 PDCD11 HTATSF1 DLD PCNT | 7.40e-07 | 1487 | 108 | 18 | 33957083 | |
| Pubmed | ZNF609 MAP1B LUC7L3 EML4 NACA AP3B1 FAM120A SLTM ZNF638 KMT2A ANKRD17 ARHGAP21 | 8.95e-07 | 650 | 108 | 12 | 38777146 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 9.60e-07 | 330 | 108 | 9 | 33301849 | |
| Pubmed | ZNF609 RARS1 LUC7L3 CBX3 RFC1 MYEF2 PPIG FAM120A RNPS1 ANKRD17 DLD THRAP3 | 9.69e-07 | 655 | 108 | 12 | 35819319 | |
| Pubmed | 1.01e-06 | 332 | 108 | 9 | 25693804 | ||
| Pubmed | The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. | 1.01e-06 | 7 | 108 | 3 | 15856011 | |
| Pubmed | NACA CBX3 SRP14 NUP58 PPIG SAFB RNPS1 PA2G4 DLD PAK1IP1 THRAP3 TOP2A | 1.05e-06 | 660 | 108 | 12 | 32780723 | |
| Pubmed | 1.20e-06 | 339 | 108 | 9 | 30415952 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | MAP1B LUC7L3 NACA SRP14 UPF3B RFC1 YTHDC1 MYEF2 FAM120A PDCD11 ANKRD17 THRAP3 | 1.39e-06 | 678 | 108 | 12 | 30209976 |
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 32479599 | ||
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 21873227 | ||
| Pubmed | Vezf1 protein binding sites genome-wide are associated with pausing of elongating RNA polymerase II. | 1.61e-06 | 8 | 108 | 3 | 22308494 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.01e-06 | 361 | 108 | 9 | 26167880 | |
| Pubmed | SGIP1 MAP1B SYNE1 KTN1 UPF3B AP3B1 MYEF2 WDR47 USP31 SAFB FAM120A AP3B2 KMT2A DLD DLG2 THRAP3 ARHGAP21 | 2.01e-06 | 1431 | 108 | 17 | 37142655 | |
| Pubmed | MAP1B LUC7L3 FLYWCH2 KTN1 NACA CBX3 RFC1 RAB3GAP1 FAM120A CEBPZ PA2G4 FANCI PDCD11 KMT2A CABIN1 THRAP3 TOP2A | 2.19e-06 | 1440 | 108 | 17 | 30833792 | |
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 24565118 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.45e-06 | 370 | 108 | 9 | 22922362 | |
| Pubmed | 2.88e-06 | 281 | 108 | 8 | 24163370 | ||
| Pubmed | 3.12e-06 | 72 | 108 | 5 | 33106477 | ||
| Pubmed | Human mediator subunit MED26 functions as a docking site for transcription elongation factors. | 3.34e-06 | 73 | 108 | 5 | 21729782 | |
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 16215946 | ||
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 19000783 | ||
| Pubmed | 4.12e-06 | 295 | 108 | 8 | 26209609 | ||
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 24367103 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MAP1B KTN1 NACA CBX3 RFC1 USP19 SAFB PA2G4 SLTM PDCD11 HTATSF1 ANKRD17 DLD THRAP3 TOP2A ILKAP | 5.02e-06 | 1367 | 108 | 16 | 32687490 |
| Pubmed | 5.31e-06 | 407 | 108 | 9 | 12693553 | ||
| Pubmed | 6.34e-06 | 222 | 108 | 7 | 37071664 | ||
| Pubmed | ZC3H13 OBSCN ARHGEF18 CHD2 AP3B1 MESD PA2G4 SLTM ZNF638 ANKRD17 AFF1 ARHGAP21 AFF4 PCNT | 6.90e-06 | 1084 | 108 | 14 | 11544199 | |
| Pubmed | 6.97e-06 | 317 | 108 | 8 | 30997501 | ||
| Interaction | SMC5 interactions | ZNF609 MAP1B LUC7L3 CENPC ATAD5 EML4 ZC3H13 KTN1 HMGXB4 CBX3 SRP14 REV3L RFC1 MED1 RREB1 SAFB CEBPZ PA2G4 FANCI SLTM ZNF638 PDCD11 HTATSF1 KMT2A MLLT1 NIPBL THRAP3 TOP2A AFF4 NSMCE1 ILKAP | 4.93e-16 | 1000 | 107 | 31 | int:SMC5 |
| Interaction | DDX23 interactions | MAP1B LUC7L3 CENPC SYNE1 ZC3H13 CHD2 YTHDC1 PPIG SAFB RNPS1 CEBPZ SLTM ZNF638 PDCD11 MLLT1 DLD THRAP3 TOP2A AFF4 | 8.00e-12 | 480 | 107 | 19 | int:DDX23 |
| Interaction | MEN1 interactions | ZNF609 LUC7L3 ZC3H13 KTN1 CBX3 SRP14 RFC1 MED1 YTHDC1 MYEF2 SAFB FAM120A PHF20L1 RNPS1 CEBPZ FANCI SLTM ZNF638 PDCD11 KMT2A ANKRD17 PAK1IP1 THRAP3 TOP2A AFF4 | 1.13e-10 | 1029 | 107 | 25 | int:MEN1 |
| Interaction | H3-3A interactions | CENPC ATAD5 EML4 HMGXB4 CBX3 CHD2 RFC1 MED1 RREB1 PHF20L1 RNPS1 FANCI KMT2A MLLT3 MRGBP CABIN1 NIPBL THRAP3 TOP2A AFF4 ILKAP | 3.47e-10 | 749 | 107 | 21 | int:H3-3A |
| Interaction | NAA40 interactions | MAP1B FLYWCH2 ATAD5 KTN1 NACA CBX3 UPF3B RFC1 MED1 SAFB RNPS1 PA2G4 ZNF638 HTATSF1 KMT2A ANKRD17 DLD NIPBL ARHGAP21 TOP2A AFF4 PCNT ILKAP | 1.35e-09 | 978 | 107 | 23 | int:NAA40 |
| Interaction | BMI1 interactions | LUC7L3 SYNE1 ZC3H13 KTN1 CBX3 SRP14 ZNF385B TRAPPC8 YTHDC1 MYEF2 FAM120A RNPS1 SLTM ZNF638 PDCD11 KMT2A MLLT1 THRAP3 TOP2A | 1.70e-09 | 659 | 107 | 19 | int:BMI1 |
| Interaction | ZNF330 interactions | ZNF536 CENPC ATAD5 HMGXB4 CBX3 RFC1 RREB1 YTHDC1 CEBPZ FANCI PDCD11 KMT2A MLLT1 NIPBL TOP2A AFF4 | 1.74e-09 | 446 | 107 | 16 | int:ZNF330 |
| Interaction | NUP43 interactions | ZNF609 LUC7L3 CENPC ZC3H13 MUC19 RFC1 YTHDC1 FSIP2 SAFB PHF20L1 RNPS1 CEBPZ FANCI PDCD11 KMT2A ELF4 NIPBL TOP2A | 4.90e-09 | 625 | 107 | 18 | int:NUP43 |
| Interaction | SNRNP70 interactions | MAP1B LUC7L3 EML4 ZC3H13 SRP14 UPF3B RFC1 DRAP1 YTHDC1 MYEF2 PPIG RAB3GAP1 SAFB FAM120A RNPS1 FANCI SLTM ZNF638 HTATSF1 PAK1IP1 THRAP3 TOP2A | 8.27e-09 | 984 | 107 | 22 | int:SNRNP70 |
| Interaction | DHX40 interactions | ZNF536 CENPC ZC3H13 KTN1 RREB1 YTHDC1 SAFB CEBPZ SLTM ZNF638 PDCD11 THRAP3 | 8.53e-09 | 249 | 107 | 12 | int:DHX40 |
| Interaction | MYCN interactions | ZNF609 TFAP2D MAP1B SYNE1 ZC3H13 KTN1 NACA HMGXB4 CBX3 SRP14 CHD2 UPF3B YTHDC1 MYEF2 PPIG SAFB FAM120A RNPS1 CEBPZ SLTM ZNF638 PDCD11 KMT2A ANKRD17 PAK1IP1 THRAP3 | 8.96e-09 | 1373 | 107 | 26 | int:MYCN |
| Interaction | CENPA interactions | ZNF536 CENPC ATAD5 ZC3H13 HMGXB4 CBX3 RFC1 RREB1 CEBPZ PDCD11 KMT2A MLLT1 NIPBL TOP2A | 1.27e-08 | 377 | 107 | 14 | int:CENPA |
| Interaction | CDK9 interactions | EML4 ZC3H13 AGR2 CBX3 SRP14 MED1 SAFB SLTM ZNF638 PDCD11 HTATSF1 KMT2A MLLT1 DLD AFF1 MLLT3 AFF4 ILKAP | 2.02e-08 | 685 | 107 | 18 | int:CDK9 |
| Interaction | TERF2IP interactions | ZNF536 ZNF609 CENPC ATAD5 HMGXB4 CBX3 SRP14 RFC1 MED1 RREB1 ZNF638 HTATSF1 KMT2A NIPBL TOP2A AFF4 | 3.51e-08 | 552 | 107 | 16 | int:TERF2IP |
| Interaction | SRPK2 interactions | LUC7L3 ZC3H13 HMGXB4 CHD2 UPF3B DRAP1 YTHDC1 MYEF2 PPIG SAFB RNPS1 CEBPZ SLTM ZNF638 PDCD11 HTATSF1 THRAP3 TOP2A | 4.04e-08 | 717 | 107 | 18 | int:SRPK2 |
| Interaction | DOT1L interactions | LUC7L3 ZC3H13 KTN1 RFC1 YTHDC1 SAFB FAM120A RNPS1 CEBPZ SLTM ZNF638 PDCD11 KMT2A MLLT1 AFF1 MLLT3 PAK1IP1 THRAP3 TOP2A | 4.47e-08 | 807 | 107 | 19 | int:DOT1L |
| Interaction | H3C3 interactions | CENPC ATAD5 HMGXB4 CBX3 RFC1 MED1 RREB1 FSIP2 FANCI KMT2A MRGBP NIPBL TOP2A AFF4 NSMCE1 | 5.49e-08 | 495 | 107 | 15 | int:H3C3 |
| Interaction | SIRT7 interactions | MAP1B ZC3H13 CBX3 CHD2 RFC1 MYEF2 FAM120A CEBPZ FANCI SLTM ZNF638 PDCD11 KMT2A ANKRD17 DLD NIPBL TOP2A PCNT | 7.05e-08 | 744 | 107 | 18 | int:SIRT7 |
| Interaction | H3C1 interactions | CENPC FLYWCH2 ATAD5 SYNE1 NACA HMGXB4 CBX3 SRP14 RFC1 ESCO1 ZNF638 KMT2A MLLT1 MLLT3 CABIN1 NIPBL THRAP3 TOP2A AFF4 | 2.48e-07 | 901 | 107 | 19 | int:H3C1 |
| Interaction | NR2C2 interactions | RARS1 LUC7L3 ZC3H13 NACA CBX3 SRP14 CHD2 RFC1 RREB1 AP3B1 YTHDC1 PPIG SAFB FAM120A RNPS1 CEBPZ PA2G4 PDCD11 KMT2A DLD PAK1IP1 NIPBL THRAP3 TOP2A | 2.52e-07 | 1403 | 107 | 24 | int:NR2C2 |
| Interaction | CBX3 interactions | ATXN7L2 RARS1 CENPC ATAD5 ZC3H13 AGR2 HMGXB4 CBX3 RFC1 MED1 RREB1 HTATSF1 KMT2A NIPBL TOP2A ILKAP | 2.99e-07 | 646 | 107 | 16 | int:CBX3 |
| Interaction | SOX2 interactions | ZNF536 ZNF609 RARS1 MAP1B ATAD5 CBX3 SRP14 UPF3B RFC1 MED1 MYEF2 OTUD7B FAM120A PHF20L1 SLTM ZNF638 PDCD11 KMT2A ANKRD17 MLLT1 NIPBL THRAP3 ARHGAP21 PCNT | 3.22e-07 | 1422 | 107 | 24 | int:SOX2 |
| Interaction | H2BC8 interactions | CENPC FLYWCH2 ATAD5 HMGXB4 CBX3 UPF3B RFC1 RREB1 FANCI KMT2A DLD MRGBP NIPBL TOP2A ILKAP | 3.86e-07 | 576 | 107 | 15 | int:H2BC8 |
| Interaction | EAF1 interactions | 4.09e-07 | 128 | 107 | 8 | int:EAF1 | |
| Interaction | EED interactions | RARS1 MAP1B LUC7L3 CENPC ZC3H13 HMGXB4 OBSCN CBX3 SRP14 CHD2 AP3B1 MYEF2 RAB3GAP1 SAFB RNPS1 CEBPZ TTC21B SLTM ZNF638 PDCD11 NIPBL THRAP3 TOP2A PCNT | 4.32e-07 | 1445 | 107 | 24 | int:EED |
| Interaction | PYHIN1 interactions | MAP1B LUC7L3 SRP14 RREB1 YTHDC1 MYEF2 SAFB FAM120A HTATSF1 ANKRD17 CABIN1 TOP2A | 4.48e-07 | 358 | 107 | 12 | int:PYHIN1 |
| Interaction | CIT interactions | RARS1 LUC7L3 SYNE1 ZC3H13 KTN1 NACA CBX3 SRP14 CHD2 UPF3B MED1 RREB1 SAFB FAM120A RNPS1 CEBPZ PA2G4 FANCI ZNF638 PDCD11 KMT2A NIPBL THRAP3 TOP2A | 4.59e-07 | 1450 | 107 | 24 | int:CIT |
| Interaction | HDLBP interactions | LUC7L3 AGR2 NACA DAB1 CBX3 SRP14 CHD2 UPF3B RFC1 AP3B1 FAM120A RNPS1 PA2G4 KMT2A DLD PAK1IP1 ARHGAP18 THRAP3 | 5.49e-07 | 855 | 107 | 18 | int:HDLBP |
| Interaction | APEX1 interactions | ZNF536 RARS1 CENPC FLYWCH2 ATAD5 KTN1 AGR2 RFC1 RREB1 YTHDC1 DNAH14 USP19 SAFB RNPS1 CEBPZ FANCI ZNF638 PDCD11 KMT2A NIPBL THRAP3 AFF4 | 7.24e-07 | 1271 | 107 | 22 | int:APEX1 |
| Interaction | ZC3H18 interactions | RARS1 LUC7L3 ZC3H13 NACA SRP14 YTHDC1 MYEF2 PPIG SAFB RNPS1 CEBPZ PA2G4 SLTM PDCD11 PAK1IP1 THRAP3 TOP2A NSMCE1 | 7.93e-07 | 877 | 107 | 18 | int:ZC3H18 |
| Interaction | H2BC21 interactions | MAP1B ATAD5 HMGXB4 OBSCN CBX3 RFC1 DRAP1 RREB1 ESCO1 MESD ZNF638 KMT2A MLLT1 MRGBP NIPBL TOP2A | 8.03e-07 | 696 | 107 | 16 | int:H2BC21 |
| Interaction | RAD18 interactions | RARS1 LUC7L3 ZC3H13 CBX3 SRP14 AP3B1 PPIG SAFB FAM120A FANCI ZNF638 THRAP3 TOP2A | 9.24e-07 | 457 | 107 | 13 | int:RAD18 |
| Interaction | FMR1 interactions | MAP1B CBX3 ARHGEF18 WDR47 FAM120A ANKRD17 DLD DLG2 NIPBL THRAP3 ARHGAP21 TOP2A AFF4 PCNT | 9.43e-07 | 536 | 107 | 14 | int:FMR1 |
| Interaction | IFI16 interactions | MAP1B SYNE1 KTN1 OBSCN CBX3 UPF3B NUP58 RFC1 YTHDC1 SAFB CEBPZ SLTM ZNF638 PDCD11 PAK1IP1 TOP2A | 1.12e-06 | 714 | 107 | 16 | int:IFI16 |
| Interaction | FGFBP1 interactions | RFC1 AP3B1 FAM120A CEBPZ SLTM ZNF638 PDCD11 KMT2A ANKRD17 PAK1IP1 | 1.13e-06 | 257 | 107 | 10 | int:FGFBP1 |
| Interaction | OBSL1 interactions | LUC7L3 SYNE1 CBX3 NUP58 RFC1 YTHDC1 MYEF2 SAFB RNPS1 CEBPZ PA2G4 SLTM ZNF638 PDCD11 NIPBL THRAP3 TOP2A PCNT | 1.19e-06 | 902 | 107 | 18 | int:OBSL1 |
| Interaction | UHRF2 interactions | 1.21e-06 | 200 | 107 | 9 | int:UHRF2 | |
| Interaction | SUZ12 interactions | LUC7L3 SYNE1 ZC3H13 HMGXB4 CBX3 CHD2 UPF3B YTHDC1 RNPS1 SLTM ZNF638 PDCD11 HTATSF1 THRAP3 PCNT | 1.56e-06 | 644 | 107 | 15 | int:SUZ12 |
| Interaction | MED26 interactions | 1.65e-06 | 107 | 107 | 7 | int:MED26 | |
| Interaction | POLR1G interactions | CENPC ATAD5 CHD2 RFC1 RREB1 CEBPZ PDCD11 KMT2A MLLT1 DLD NIPBL TOP2A AFF4 | 1.96e-06 | 489 | 107 | 13 | int:POLR1G |
| Interaction | PIP4K2A interactions | 2.28e-06 | 216 | 107 | 9 | int:PIP4K2A | |
| Interaction | CHD3 interactions | LUC7L3 ATAD5 ZC3H13 HMGXB4 CBX3 RFC1 SAFB FAM120A PHF20L1 CEBPZ PDCD11 HTATSF1 KMT2A THRAP3 TOP2A PCNT | 2.40e-06 | 757 | 107 | 16 | int:CHD3 |
| Interaction | CLK1 interactions | 2.56e-06 | 219 | 107 | 9 | int:CLK1 | |
| Interaction | CLK3 interactions | 2.65e-06 | 220 | 107 | 9 | int:CLK3 | |
| Interaction | RNF2 interactions | RARS1 LUC7L3 SYNE1 CBX3 MYEF2 USP19 FAM120A RNPS1 CEBPZ ZNF638 PDCD11 KMT2A MLLT1 MLLT3 MRGBP THRAP3 TOP2A | 3.04e-06 | 866 | 107 | 17 | int:RNF2 |
| Interaction | CAMKV interactions | 3.17e-06 | 118 | 107 | 7 | int:CAMKV | |
| Interaction | CCNT1 interactions | 3.19e-06 | 225 | 107 | 9 | int:CCNT1 | |
| Interaction | SSRP1 interactions | ZC3H13 HMGXB4 CBX3 CHD2 RFC1 TRAPPC8 YTHDC1 SAFB RNPS1 SLTM ZNF638 KMT2A NIPBL THRAP3 TOP2A | 3.33e-06 | 685 | 107 | 15 | int:SSRP1 |
| Interaction | MECP2 interactions | MAP1B LUC7L3 SYNE1 ZC3H13 HMGXB4 CBX3 SRP14 CHD2 MED1 YTHDC1 MYEF2 PPIG SAFB CEBPZ SLTM ZNF638 PDCD11 PAK1IP1 NIPBL THRAP3 AFF4 | 3.45e-06 | 1287 | 107 | 21 | int:MECP2 |
| Interaction | DHX8 interactions | LUC7L3 ZC3H13 CBX3 SAFB RNPS1 SLTM ZNF638 HTATSF1 THRAP3 AFF4 | 3.56e-06 | 292 | 107 | 10 | int:DHX8 |
| Interaction | BIRC3 interactions | RARS1 LUC7L3 SYNE1 KTN1 NACA CBX3 SRP14 RFC1 AP3B1 USP19 SAFB RNPS1 CEBPZ PA2G4 FANCI SLTM PDCD11 DLD PAK1IP1 THRAP3 TOP2A | 6.03e-06 | 1334 | 107 | 21 | int:BIRC3 |
| Interaction | MLLT3 interactions | 6.05e-06 | 85 | 107 | 6 | int:MLLT3 | |
| Interaction | SNRNP40 interactions | ZNF609 LUC7L3 CENPC ATAD5 ZC3H13 RFC1 YTHDC1 PHF20L1 CEBPZ FANCI PDCD11 HTATSF1 KMT2A TOP2A | 6.98e-06 | 637 | 107 | 14 | int:SNRNP40 |
| Interaction | COIL interactions | ZNF536 CENPC CBX3 RREB1 YTHDC1 CEBPZ PDCD11 HTATSF1 MLLT1 MLLT3 NIPBL TOP2A AFF4 | 7.31e-06 | 552 | 107 | 13 | int:COIL |
| Interaction | FEZ1 interactions | 8.43e-06 | 90 | 107 | 6 | int:FEZ1 | |
| Interaction | CHD4 interactions | LUC7L3 EML4 AGR2 HMGXB4 CBX3 RFC1 TRAPPC8 SAFB PHF20L1 ZNF638 PDCD11 HTATSF1 KMT2A MLLT3 THRAP3 TOP2A PCNT | 8.75e-06 | 938 | 107 | 17 | int:CHD4 |
| Interaction | ELL3 interactions | 1.03e-05 | 26 | 107 | 4 | int:ELL3 | |
| Interaction | RBM4B interactions | 1.09e-05 | 262 | 107 | 9 | int:RBM4B | |
| Interaction | MED17 interactions | 1.24e-05 | 202 | 107 | 8 | int:MED17 | |
| Interaction | BRD3 interactions | CENPC ATAD5 HMGXB4 CBX3 RFC1 MED1 RAB11FIP1 RNPS1 KMT2A MRGBP NIPBL TOP2A | 1.24e-05 | 494 | 107 | 12 | int:BRD3 |
| Interaction | PRC1 interactions | LUC7L3 SYNE1 KTN1 NACA CBX3 SRP14 RWDD3 YTHDC1 SAFB RNPS1 CEBPZ PA2G4 SLTM ZNF638 PDCD11 THRAP3 TOP2A | 1.41e-05 | 973 | 107 | 17 | int:PRC1 |
| Interaction | RPL31 interactions | CENPC ATAD5 ZC3H13 AGR2 NACA UPF3B RFC1 YTHDC1 FAM120A CEBPZ FANCI PDCD11 PAK1IP1 TOP2A | 1.46e-05 | 680 | 107 | 14 | int:RPL31 |
| Interaction | ZNF263 interactions | 1.47e-05 | 149 | 107 | 7 | int:ZNF263 | |
| Interaction | SRSF6 interactions | CENPC ZC3H13 YTHDC1 PPIG FAM120A RNPS1 CEBPZ ZNF638 PDCD11 KMT2A PAK1IP1 THRAP3 | 1.48e-05 | 503 | 107 | 12 | int:SRSF6 |
| Interaction | CEBPB interactions | RARS1 LUC7L3 KTN1 NACA CBX3 SRP14 RFC1 MED1 DRAP1 YTHDC1 RNPS1 PA2G4 ZNF638 HTATSF1 MLLT1 DLD AFF1 MLLT3 THRAP3 TOP2A ILKAP | 1.99e-05 | 1443 | 107 | 21 | int:CEBPB |
| Interaction | HDAC1 interactions | ZNF536 ZNF609 LUC7L3 EML4 RFC1 RREB1 ESCO1 USP19 PHF20L1 C22orf31 ZNF638 KMT2A ANKRD17 AFF1 CABIN1 ARHGAP21 TOP2A PCNT | 2.03e-05 | 1108 | 107 | 18 | int:HDAC1 |
| Interaction | AFF1 interactions | 2.65e-05 | 66 | 107 | 5 | int:AFF1 | |
| Interaction | FOXK2 interactions | 2.69e-05 | 225 | 107 | 8 | int:FOXK2 | |
| Interaction | ELL2 interactions | 2.73e-05 | 33 | 107 | 4 | int:ELL2 | |
| Interaction | ZBTB2 interactions | LUC7L3 YTHDC1 PPIG MESD SAFB RNPS1 CEBPZ PDCD11 ARHGAP18 THRAP3 TOP2A | 2.75e-05 | 450 | 107 | 11 | int:ZBTB2 |
| Interaction | CEBPA interactions | ZNF609 RARS1 FLYWCH2 SRP14 UPF3B RFC1 MED1 RREB1 SAFB FAM120A RNPS1 CEBPZ PA2G4 FANCI PDCD11 KMT2A NIPBL THRAP3 TOP2A | 2.76e-05 | 1245 | 107 | 19 | int:CEBPA |
| Interaction | POLR2A interactions | ZC3H13 AGR2 CBX3 MED1 DRAP1 PPIG SAFB HTATSF1 KMT2A MLLT1 AFF1 CABIN1 | 2.77e-05 | 536 | 107 | 12 | int:POLR2A |
| Interaction | KCTD12 interactions | 3.26e-05 | 114 | 107 | 6 | int:KCTD12 | |
| Interaction | AGR2 interactions | TFAP2D RARS1 SYNE1 KTN1 AGR2 MUC19 CBX3 NUP58 AP3B1 TMEM200A MYEF2 SAFB SLTM KMT2A DLD ARHGAP18 | 3.29e-05 | 934 | 107 | 16 | int:AGR2 |
| Interaction | DENND2D interactions | 3.88e-05 | 36 | 107 | 4 | int:DENND2D | |
| Interaction | KMT2A interactions | 4.54e-05 | 314 | 107 | 9 | int:KMT2A | |
| Interaction | PLCD3 interactions | 4.56e-05 | 121 | 107 | 6 | int:PLCD3 | |
| Interaction | SRPK1 interactions | LUC7L3 CBX3 YTHDC1 PPIG SAFB RNPS1 CEBPZ PDCD11 THRAP3 TOP2A NOVA1 | 4.67e-05 | 477 | 107 | 11 | int:SRPK1 |
| Interaction | MLLT1 interactions | 5.00e-05 | 123 | 107 | 6 | int:MLLT1 | |
| Interaction | RNF151 interactions | 5.00e-05 | 123 | 107 | 6 | int:RNF151 | |
| Interaction | SLX4 interactions | RARS1 NACA CBX3 REV3L AP3B1 SAFB FANCI PDCD11 MLLT1 NIPBL AFF4 ILKAP | 5.20e-05 | 572 | 107 | 12 | int:SLX4 |
| Interaction | H2BC12 interactions | 5.52e-05 | 322 | 107 | 9 | int:H2BC12 | |
| Interaction | BORCS8-MEF2B interactions | 6.32e-05 | 15 | 107 | 3 | int:BORCS8-MEF2B | |
| Interaction | ELL interactions | 6.73e-05 | 80 | 107 | 5 | int:ELL | |
| Interaction | GATA4 interactions | 6.75e-05 | 411 | 107 | 10 | int:GATA4 | |
| Interaction | EFTUD2 interactions | RARS1 LUC7L3 FLYWCH2 EML4 KTN1 AGR2 NACA CBX3 SRP14 UPF3B RFC1 AP3B1 RNPS1 CEBPZ PA2G4 ZNF638 HTATSF1 NIPBL THRAP3 TOP2A | 6.82e-05 | 1449 | 107 | 20 | int:EFTUD2 |
| Interaction | GAPDH interactions | RARS1 MAP1B AGR2 OBSCN REV3L RFC1 DRAP1 USP31 PA2G4 SLTM NIPBL ARHGAP21 AFF4 | 7.04e-05 | 686 | 107 | 13 | int:GAPDH |
| Interaction | H2BC4 interactions | 7.27e-05 | 259 | 107 | 8 | int:H2BC4 | |
| Interaction | LINC00240 interactions | 7.75e-05 | 16 | 107 | 3 | int:LINC00240 | |
| Interaction | USP36 interactions | RARS1 SRP14 UPF3B RFC1 MYEF2 CEBPZ FANCI ZNF638 PDCD11 PAK1IP1 ARHGAP21 TOP2A | 8.07e-05 | 599 | 107 | 12 | int:USP36 |
| Interaction | TOP1 interactions | AGR2 CBX3 RFC1 YTHDC1 SAFB RNPS1 PA2G4 SLTM ZNF638 KMT2A NIPBL THRAP3 TOP2A | 8.14e-05 | 696 | 107 | 13 | int:TOP1 |
| Interaction | FGF12 interactions | 1.00e-04 | 87 | 107 | 5 | int:FGF12 | |
| Interaction | FOXP3 interactions | 1.02e-04 | 432 | 107 | 10 | int:FOXP3 | |
| Interaction | EPB41L3 interactions | 1.02e-04 | 272 | 107 | 8 | int:EPB41L3 | |
| Interaction | DDX21 interactions | MAP1B SRP14 CHD2 YTHDC1 SAFB FAM120A RNPS1 CEBPZ PA2G4 SLTM PDCD11 THRAP3 TOP2A | 1.11e-04 | 718 | 107 | 13 | int:DDX21 |
| Interaction | NEIL1 interactions | 1.13e-04 | 276 | 107 | 8 | int:NEIL1 | |
| Interaction | ATG16L1 interactions | RARS1 EML4 SPEG ZC3H13 KTN1 CBX3 SRP14 MED1 RAB11FIP1 YTHDC1 MYEF2 SAFB FAM120A PA2G4 SLTM ZNF638 TOP2A | 1.28e-04 | 1161 | 107 | 17 | int:ATG16L1 |
| Interaction | H2BC13 interactions | 1.30e-04 | 210 | 107 | 7 | int:H2BC13 | |
| Interaction | NFKBIL1 interactions | 1.38e-04 | 93 | 107 | 5 | int:NFKBIL1 | |
| Interaction | APOBEC3D interactions | 1.39e-04 | 148 | 107 | 6 | int:APOBEC3D | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 2.14e-08 | 9 | 67 | 4 | 1280 | |
| GeneFamily | Super elongation complex|YEATS domain containing | 8.08e-05 | 4 | 67 | 2 | 1283 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 8.08e-05 | 4 | 67 | 2 | 1145 | |
| GeneFamily | RNA binding motif containing | 1.37e-04 | 213 | 67 | 6 | 725 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | LUC7L3 CENPC KTN1 CBX3 REV3L RFC1 TRAPPC8 AP3B1 MYEF2 PPIG PHF20L1 CEBPZ ZNF638 HTATSF1 NIPBL | 8.24e-08 | 656 | 108 | 15 | M18979 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | NPHP1 CENPC NACA OBSCN CBX3 ARHGEF18 RFC1 MED1 RWDD3 RREB1 AP3B1 YTHDC1 USP19 PPIG SAFB FAM120A CEBPZ FANCI FAM76A DLD TOP2A | 2.17e-07 | 1394 | 108 | 21 | M9585 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | LUC7L3 CENPC ZC3H13 KTN1 SRP14 UPF3B RWDD3 YTHDC1 SLTM HTATSF1 ANKRD17 | 1.65e-06 | 429 | 108 | 11 | M29 |
| Coexpression | GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN | 1.70e-06 | 198 | 108 | 8 | M8768 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ZNF609 CENPC EML4 SYNE1 KTN1 CBX3 CHD2 REV3L MED1 DRAP1 TRAPPC8 YTHDC1 PPIG ZNF276 PHF20L1 ZNF638 KMT2A NIPBL THRAP3 | 1.03e-05 | 1492 | 108 | 19 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAP1B CENPC HMGXB4 REV3L MED1 TRAPPC8 AP3B1 RAB3GAP1 ZNF638 ANKRD17 AFF1 NIPBL TOP2A PCNT | 1.15e-05 | 856 | 108 | 14 | M4500 |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 3.07e-05 | 481 | 108 | 10 | M3898 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 5.90e-05 | 323 | 108 | 8 | M9150 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 6.62e-05 | 166 | 108 | 6 | M8129 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 1.32e-04 | 363 | 108 | 8 | M41103 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MAP1B HMGXB4 REV3L TRAPPC8 RAB3GAP1 ZNF638 ANKRD17 AFF1 TOP2A | 1.36e-04 | 466 | 108 | 9 | M13522 |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP | 1.69e-04 | 197 | 108 | 6 | M4211 | |
| Coexpression | FISCHER_DREAM_TARGETS | CENPC ATAD5 HMGXB4 CBX3 NUP58 RFC1 RNPS1 FANCI ANKRD17 NIPBL THRAP3 TOP2A PCNT | 1.78e-04 | 969 | 108 | 13 | M149 |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 1.79e-04 | 199 | 108 | 6 | M6839 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 1.79e-04 | 199 | 108 | 6 | M3186 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN | 1.84e-04 | 200 | 108 | 6 | M5081 | |
| Coexpression | GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN | 1.84e-04 | 200 | 108 | 6 | M5806 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 1.84e-04 | 200 | 108 | 6 | M7839 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP | 1.84e-04 | 200 | 108 | 6 | M5781 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | RARS1 CBX3 NUP58 RFC1 USP31 CEBPZ HTATSF1 ELF4 NIPBL TOP2A AFF4 | 1.94e-04 | 721 | 108 | 11 | M10237 |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.99e-04 | 289 | 108 | 7 | M2196 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | MAP1B CENPC ATAD5 KTN1 DAB1 FHOD3 RWDD3 ESCO1 SAFB PHF20L1 CEBPZ SLTM ZNF638 MLLT3 NIPBL THRAP3 NOVA1 PCNT | 1.21e-10 | 532 | 105 | 18 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ZNF536 MAP1B LUC7L3 SWT1 ATAD5 KTN1 FHOD3 CHD2 UPF3B AP3B1 WDR47 PPIG SAFB CEBPZ ERCC6L2 SLTM MLLT3 NIPBL ARHGAP21 AFF4 NOVA1 | 6.18e-10 | 831 | 105 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | LUC7L3 ATAD5 CHD2 UPF3B REV3L AP3B1 PPIG SAFB CEBPZ SLTM MLLT3 NIPBL ARHGAP21 | 4.64e-09 | 311 | 105 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ZNF536 MAP1B LUC7L3 ATAD5 KTN1 FHOD3 CHD2 UPF3B REV3L AP3B1 WDR47 PPIG SAFB PLEKHM2 CEBPZ SLTM MLLT3 NIPBL ARHGAP21 NOVA1 PCNT | 1.34e-08 | 989 | 105 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ZNF536 MAP1B ATAD5 KTN1 DAB1 FHOD3 CHD2 TMEM200A SAFB CEBPZ TMEM38A SLTM MED12L MLLT3 NOVA1 PCNT | 1.34e-07 | 654 | 105 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ZNF536 MAP1B ATAD5 KTN1 DAB1 FHOD3 CHD2 SAFB CEBPZ MED12L NOVA1 | 6.92e-07 | 328 | 105 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | ZNF536 ZNF609 MAP1B LUC7L3 CENPC ATAD5 ZC3H13 KTN1 FHOD3 UPF3B REV3L RFC1 MYEF2 PPIG PLEKHM2 AP3B2 SLTM MLLT3 NIPBL THRAP3 ARHGAP21 TOP2A | 7.59e-07 | 1370 | 105 | 22 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.92e-07 | 204 | 105 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ZNF536 MAP1B LUC7L3 CENPC SWT1 ATAD5 ZC3H13 KTN1 AGR2 DAB1 FHOD3 UPF3B REV3L RFC1 RWDD3 PPIG AP3B2 SLTM NIPBL THRAP3 ARHGAP21 TOP2A | 2.16e-06 | 1459 | 105 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.64e-06 | 259 | 105 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ZNF536 LUC7L3 FHOD3 CHD2 AP3B1 TMEM200A PLEKHM2 TMEM38A SLTM | 8.12e-06 | 271 | 105 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ZNF536 SGIP1 LUC7L3 CENPC SWT1 ATAD5 EML4 ZNF385B UPF3B REV3L RFC1 AP4E1 PPIG SLTM ZNF638 AFF1 MLLT3 NIPBL THRAP3 | 1.10e-05 | 1252 | 105 | 19 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | LUC7L3 CENPC SWT1 ATAD5 ZC3H13 KTN1 AGR2 DAB1 FHOD3 UPF3B REV3L RFC1 RWDD3 PPIG SLTM NIPBL THRAP3 ARHGAP21 TOP2A | 1.16e-05 | 1257 | 105 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 3.53e-05 | 124 | 105 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.90e-05 | 186 | 105 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.78e-05 | 192 | 105 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 6.68e-05 | 139 | 105 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | ZNF536 TFAP2D LUC7L3 FLYWCH2 FHOD3 CHD2 RFC1 AP3B1 TMEM200A ZNF276 PLEKHM2 TMEM38A SLTM ZNF638 DLG2 | 9.19e-05 | 978 | 105 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | ZNF536 MAP1B ATAD5 KTN1 DAB1 FHOD3 CHD2 MYEF2 SAFB ZNF276 CEBPZ SLTM MED12L NOVA1 PCNT | 9.72e-05 | 983 | 105 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | MAP1B LUC7L3 ATAD5 ZC3H13 KTN1 DAB1 FHOD3 RFC1 RAB11FIP1 PPIG CEBPZ PA2G4 FAM76A SLTM PDCD11 AFF1 MLLT3 TOP2A | 1.01e-04 | 1347 | 105 | 18 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ATAD5 ZC3H13 CHD2 TRAPPC8 AP3B1 YTHDC1 AP4E1 PPIG FAM120A ANKRD17 TOP2A | 1.10e-04 | 564 | 105 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.18e-04 | 298 | 105 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.52e-04 | 231 | 105 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.56e-04 | 232 | 105 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 1.81e-04 | 498 | 105 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | LUC7L3 ATAD5 ZC3H13 KTN1 DAB1 FHOD3 RFC1 PPIG CEBPZ PA2G4 FAM76A SLTM PDCD11 AFF1 MLLT3 TOP2A | 1.87e-04 | 1164 | 105 | 16 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_200 | 2.53e-04 | 62 | 105 | 4 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | LUC7L3 ATAD5 KTN1 CHD2 TRAPPC8 AP3B1 TMEM200A PPIG FAM120A SLTM NIPBL | 2.83e-04 | 629 | 105 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.95e-04 | 432 | 105 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.30e-04 | 361 | 105 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | ZNF536 ZNF609 MAP1B LUC7L3 ATAD5 KTN1 FHOD3 UPF3B TMEM200A MYEF2 TMEM38A MLLT3 NOVA1 | 4.61e-04 | 893 | 105 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | ZNF536 MAP1B LUC7L3 CENPC SWT1 ATAD5 ZC3H13 AGR2 DAB1 FHOD3 UPF3B WDR47 PPIG AP3B2 SLTM NIPBL THRAP3 | 5.53e-04 | 1414 | 105 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | LUC7L3 ZC3H13 HMGXB4 CHD2 RFC1 RREB1 ESCO1 PHF20L1 ZNF638 ANKRD17 THRAP3 TOP2A | 6.33e-04 | 806 | 105 | 12 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | MAP1B LUC7L3 CENPC SWT1 ATAD5 ZC3H13 DAB1 FHOD3 UPF3B WDR47 PPIG SLTM NIPBL THRAP3 | 7.24e-04 | 1060 | 105 | 14 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZNF536 MAP1B LUC7L3 CHD2 TRAPPC8 AP3B1 PPIG FAM120A TOP2A NOVA1 | 7.34e-04 | 595 | 105 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 7.52e-04 | 492 | 105 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | e10.5_NeuroEpith_LateralEmin_top-relative-expression-ranked_500_1 | 7.74e-04 | 145 | 105 | 5 | Facebase_ST1_e10.5_NeuroEpith_LateralEmin_500_1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.01e-04 | 397 | 105 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | e9.5_NeuroEpith_OverFaceMesench_top-relative-expression-ranked_250 | 9.56e-04 | 152 | 105 | 5 | Facebase_ST1_e9.5_NeuroEpith_OverFaceMesench_250 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | MAP1B LUC7L3 ZC3H13 CHD2 UPF3B YTHDC1 PPIG SLTM ZNF638 TOP2A | 5.49e-11 | 197 | 108 | 10 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.07e-08 | 199 | 108 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.07e-08 | 199 | 108 | 8 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | IIH-CD8-naive_CD4|IIH / Condition, Cell_class and T cell subcluster | 2.21e-07 | 173 | 108 | 7 | 4f2843371d18af766c1892529ce286f56c956fde | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-07 | 188 | 108 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.48e-07 | 192 | 108 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.17e-06 | 155 | 108 | 6 | 9d53caee196b5c2bbc90c4f54f693b64d4086065 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.52e-06 | 159 | 108 | 6 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 7.67e-06 | 193 | 108 | 6 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 195 | 108 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.38e-06 | 196 | 108 | 6 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 8.38e-06 | 196 | 108 | 6 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-06 | 197 | 108 | 6 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 9.13e-06 | 199 | 108 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-06 | 199 | 108 | 6 | 47466253069d4b1b8f13ce3210f434e60753b38a | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.13e-06 | 199 | 108 | 6 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 9.13e-06 | 199 | 108 | 6 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.13e-06 | 199 | 108 | 6 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.40e-06 | 200 | 108 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 123 | 108 | 5 | 87401764a073c1808f214642a9c84299c78f7ec7 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 3.36e-05 | 151 | 108 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.28e-05 | 166 | 108 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.08e-05 | 171 | 108 | 5 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.08e-05 | 171 | 108 | 5 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.78e-05 | 175 | 108 | 5 | 6751ee4b312d7f87275f2c35e5878cfc3be3ebe3 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 176 | 108 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 180 | 108 | 5 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 180 | 108 | 5 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 180 | 108 | 5 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 108 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 108 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.04e-05 | 186 | 108 | 5 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.04e-05 | 186 | 108 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 187 | 108 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 187 | 108 | 5 | 376a95ac1e38f61f8db5d23d9a905f8dae8c40b6 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 188 | 108 | 5 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 188 | 108 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 188 | 108 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 188 | 108 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 9.50e-05 | 188 | 108 | 5 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.74e-05 | 189 | 108 | 5 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-05 | 190 | 108 | 5 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-05 | 190 | 108 | 5 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 191 | 108 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 191 | 108 | 5 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-04 | 191 | 108 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 191 | 108 | 5 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.05e-04 | 192 | 108 | 5 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-04 | 192 | 108 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 192 | 108 | 5 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-04 | 193 | 108 | 5 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.07e-04 | 193 | 108 | 5 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.07e-04 | 193 | 108 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 194 | 108 | 5 | c992e3357f4bf3069f8d697803e5785e49a2ef0a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 194 | 108 | 5 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.10e-04 | 194 | 108 | 5 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 194 | 108 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.10e-04 | 194 | 108 | 5 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 194 | 108 | 5 | 7bf6edefd13047e04665dbe34051ef3f481f85a4 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.10e-04 | 194 | 108 | 5 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 194 | 108 | 5 | 19e5beae2c1f8bf42cbe618e89810ce7b01a396c | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.13e-04 | 195 | 108 | 5 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.13e-04 | 195 | 108 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 108 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 196 | 108 | 5 | efeb272bc9e37e60d15d056b7574991c5c7501bc | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-04 | 197 | 108 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-04 | 197 | 108 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.18e-04 | 197 | 108 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 197 | 108 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-04 | 197 | 108 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 198 | 108 | 5 | 63f7d25201613bd3404c28fb936954190bca91d3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 198 | 108 | 5 | a73534b6ca202c277a70a52281d5b97a3e6cb8ef | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 198 | 108 | 5 | d1e1bdd36c84e1bac21ba137f018defe98456a8c | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.21e-04 | 198 | 108 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 198 | 108 | 5 | 2ee8ac82ef1b8ebabc8dd824211bbb471f2af8ac | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.21e-04 | 198 | 108 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-04 | 198 | 108 | 5 | 36897e17de2e22ee6b23920ee6e60931903f3e5c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-04 | 199 | 108 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.24e-04 | 199 | 108 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.24e-04 | 199 | 108 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.24e-04 | 199 | 108 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.24e-04 | 199 | 108 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 1.24e-04 | 199 | 108 | 5 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 1.24e-04 | 199 | 108 | 5 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 199 | 108 | 5 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 1.24e-04 | 199 | 108 | 5 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-Neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-04 | 200 | 108 | 5 | b9538eb33ac86384e7e289a5a82fac4d56a7b9c2 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 200 | 108 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 1.27e-04 | 200 | 108 | 5 | 617a6a42f7b31eb3c45bdceaf55a591b6de7f154 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-04 | 200 | 108 | 5 | c248233b004f8ef0bab3c65ecfe295887966f2ee | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.27e-04 | 200 | 108 | 5 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.27e-04 | 200 | 108 | 5 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 200 | 108 | 5 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.26e-04 | 135 | 108 | 4 | 35928195cf34f055b353562c96f451aef2344d64 | |
| Computational | Neighborhood of BNIP2 | 7.37e-05 | 34 | 72 | 4 | GNF2_BNIP2 | |
| Computational | Neighborhood of SUFU | 1.59e-04 | 77 | 72 | 5 | GCM_SUFU | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.12e-04 | 49 | 72 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Disease | Cerebellar Ataxia | 1.25e-04 | 5 | 105 | 2 | C0007758 | |
| Disease | quality of life during menstruation measurement, breast pressure measurement | 1.86e-04 | 6 | 105 | 2 | EFO_0009366, EFO_0009393 | |
| Disease | brain volume measurement, putamen volume | 1.86e-04 | 6 | 105 | 2 | EFO_0006930, EFO_0006932 | |
| Disease | Hereditary, Type VII, Motor and Sensory Neuropathy | 1.86e-04 | 6 | 105 | 2 | C0019816 | |
| Disease | Hereditary Motor and Sensory Neuropathies | 1.86e-04 | 6 | 105 | 2 | C0027888 | |
| Disease | Dejerine-Sottas Disease (disorder) | 2.60e-04 | 7 | 105 | 2 | C0011195 | |
| Disease | Cornelia De Lange Syndrome | 3.46e-04 | 8 | 105 | 2 | C0270972 | |
| Disease | nephronophthisis (implicated_via_orthology) | 4.44e-04 | 9 | 105 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 8.09e-04 | 12 | 105 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Nephronophthisis | 9.54e-04 | 13 | 105 | 2 | C0687120 | |
| Disease | insomnia measurement | 1.06e-03 | 443 | 105 | 7 | EFO_0007876 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 1.65e-03 | 352 | 105 | 6 | EFO_0007014 | |
| Disease | JT interval | 1.97e-03 | 248 | 105 | 5 | EFO_0007885 | |
| Disease | resting heart rate | 2.01e-03 | 149 | 105 | 4 | EFO_0004351 | |
| Disease | Familial aplasia of the vermis | 2.29e-03 | 20 | 105 | 2 | cv:C0431399 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 2.52e-03 | 21 | 105 | 2 | C1292769 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 2.52e-03 | 21 | 105 | 2 | OBA_2045083 | |
| Disease | level of Phosphatidylethanolamine (16:0_18:2) in blood serum | 3.29e-03 | 24 | 105 | 2 | OBA_2045136 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSKVKEDKFKGSLSE | 496 | Q13523 | |
| KRIGASTKSKDRKTE | 596 | Q7Z4L5 | |
| RDTTVKPGAKKDTKD | 21 | O95994 | |
| RAKAKAKTGSKTDAV | 41 | Q6PI77 | |
| ASDALKNGVKKSSDK | 411 | Q96QE3 | |
| AGKNEKSDKSTSVKR | 246 | Q6ZSZ5 | |
| DSESDDSKSKKKRDA | 96 | Q13185 | |
| TSKTTRKGKEKSSEK | 1316 | Q8N7X0 | |
| EELSAKKRKKSSSEA | 291 | P42568 | |
| GIRESKESSKEKKLT | 141 | O95567 | |
| DTKDKSLKTVSSGAK | 496 | O76090 | |
| KEERKSVSGKASIKL | 1661 | O75179 | |
| GEKSVTSKSDGKKSL | 11 | Q96MT7 | |
| SKASKSSKGKDGVEV | 551 | Q5T6C5 | |
| KTEGKTSSSSKEVKE | 866 | Q9UHB7 | |
| RKTSEAAVKEGKTEK | 436 | Q7Z6R9 | |
| KRNSKAKGKSDSEDG | 741 | O00203 | |
| TKKKVPERKGEASSS | 746 | Q13367 | |
| KSKVKEAKSGETTST | 796 | Q9UPM8 | |
| TKSKDKKLSGTDSEQ | 126 | Q14919 | |
| RKKARDEGKKTSASD | 526 | Q15042 | |
| LEKKSDKGVRKAFST | 226 | A6NDH6 | |
| GSSGTETLEKKKKNS | 541 | Q6GQQ9 | |
| KKKASKTAENATSGE | 371 | Q9UQ80 | |
| SVEESGKKEKGKSIS | 891 | Q9NVI1 | |
| SDKVSRVASPKKKES | 2281 | P46821 | |
| TTDEEKKTKGRKRKT | 1761 | Q86YW9 | |
| KASREESAKKTGKSK | 161 | Q99607 | |
| KKEGDLKSRSSKEEN | 211 | Q14696 | |
| TASKDSTKVAGAKRK | 46 | Q96CP2 | |
| IDELKSKEKSSSRKG | 6326 | Q5CZC0 | |
| KRGTGNTDTKKDDEK | 256 | P29536 | |
| QDGKVTAVKSTESKK | 1346 | Q7Z5P9 | |
| KSPTSKDDKRTEGNK | 911 | Q6KC79 | |
| KDDKRTEGNKSKVDT | 916 | Q6KC79 | |
| SGTKKLKTETDKENA | 266 | Q86UP2 | |
| SKEKEKRGSDDKKSS | 376 | O95232 | |
| DKKSSVKSGSREKQS | 386 | O95232 | |
| EVAKELKSKSGESKS | 1026 | Q9NZB2 | |
| KKSSKKSARDEQGAL | 221 | Q9UGU5 | |
| KKTAKRKGSAVDASV | 36 | O95613 | |
| SKGKDQERSRSKEKS | 506 | Q13427 | |
| VRGSEEDSPKKESKK | 491 | O43719 | |
| KDGKKLSSSSKVRVE | 1661 | Q5VST9 | |
| EKDTLRDKGKKAEST | 396 | Q9BZI7 | |
| KGSISEETKQKLKSA | 2161 | Q9Y6J0 | |
| KKDSRKKGQDRSEAT | 16 | O75553 | |
| VGSKKSSTRKDKEES | 481 | Q03188 | |
| SSRKDKEGDKERKKS | 1406 | O14647 | |
| TSESKKLKVSVAKEG | 16 | Q5T1B0 | |
| KELSVSKKTAADGKR | 941 | Q2V2M9 | |
| KTEGKGAKRKTSEEE | 71 | Q9H0C8 | |
| TKVTGATKKSDGKID | 276 | P09622 | |
| AERKSASKISERKGK | 1456 | Q0VDD8 | |
| KSSDFSGEKKVGRKS | 76 | Q8IY85 | |
| VATSSSAKKATGRKK | 921 | Q03164 | |
| VIDSKGSFNDKRKKS | 621 | Q15700 | |
| EKSKENSSKVTKKSD | 6 | Q5FWF5 | |
| TLSSAAKSGTEKKKE | 106 | Q9HC35 | |
| KDKSSTRGEKVKAES | 331 | Q03111 | |
| SFEKGEQRTRKKSDK | 1296 | Q5T890 | |
| EKERESGVLKSNKKS | 246 | Q8WV22 | |
| VSTKKSKRKGTDDFD | 941 | Q03701 | |
| EKSDKDKSKVSTSGS | 1356 | Q15648 | |
| AGKESTLKRSEKRDK | 631 | O15259 | |
| DKKSDKTGTRPEDSK | 226 | Q9BVL2 | |
| QKETGATIKLSKSKD | 76 | P51513 | |
| KLEDKSSTAFGKRKE | 536 | A8MW92 | |
| SSTAFGKRKEKDKER | 541 | A8MW92 | |
| IGKKKKSRSDEEASP | 321 | Q8IWE5 | |
| GEDKKKFKTRSGETV | 446 | P54136 | |
| KIKGKNKDSGSDTAS | 176 | Q6WKZ4 | |
| KEAKESKKPESRRSS | 421 | Q6WKZ4 | |
| DEKSKDRSKDKGATK | 36 | Q15287 | |
| DRSKDKGATKESSEK | 41 | Q15287 | |
| GDSSATQKKLSKIKE | 2871 | Q8NF91 | |
| DDKTSGSKKCETKSI | 266 | Q86VY9 | |
| KEEKSDLKEKSTGSK | 61 | Q9P2K5 | |
| TAKKKQDSETERLKG | 301 | P78426 | |
| PKTKKARKDTEAGET | 236 | P35251 | |
| GKASEKSSKDKEKNS | 151 | Q9NV56 | |
| ARESSKKAESGDKEK | 321 | Q9NWH9 | |
| KKKSKFESITTNGDS | 186 | Q8TAV0 | |
| GEKDKKERKTPASST | 26 | Q5T5J6 | |
| TSDKRDSDGKKEKSS | 491 | Q15424 | |
| SSSKLAKKRKGEAER | 806 | P51825 | |
| STEEGSTKRKKSQKG | 36 | Q14690 | |
| SLSRSKGEEDDKSKK | 581 | O94967 | |
| LQKTSKVDVDSSGKK | 196 | Q9Y3V2 | |
| GLEDTTSKKKQKDRA | 16 | O94966 | |
| ERSAEKTEKTHKGSK | 751 | Q9Y2W1 | |
| GKSKKSFSRKEAEAT | 126 | A1L167 | |
| EKGTSRKHTTLKDEK | 1216 | O60673 | |
| EDTTTEEKRGKKSKS | 346 | Q15772 | |
| TDGKKKISTVVSSKE | 61 | P37108 | |
| KTDSPKSVASKADKR | 1496 | Q92766 | |
| KAFGIRKKEKDTDST | 11 | Q9BQI5 | |
| AAKASRSVAGSKKEK | 146 | O15014 | |
| VSGKKSESKEAKKSE | 391 | Q8N554 | |
| DKSEDKGKLKASSSS | 221 | Q569K4 | |
| KRGLTGDSKKATKES | 351 | Q9NWT1 | |
| EKKGSKRKSDRMEST | 41 | Q96MU7 | |
| SSKEKIQKSKGDDAT | 246 | Q8N392 | |
| EEKPSGKSSQRKSEK | 956 | O15090 | |
| IVSKAVTSKKSKGES | 1481 | P11388 | |
| SENKDTKLASREKGK | 1141 | Q9Y2L5 | |
| IKSGLKRDSKSEDKG | 1211 | Q70CQ4 | |
| KKTSSPTERKGQDKE | 216 | Q5QJ38 | |
| TKSDGKSVKKRSVSE | 21 | P01270 | |
| EESKKESETLGRKQK | 1456 | Q5T5U3 | |
| KSKEELSEGSRKKKA | 281 | Q9H6F2 | |
| ERKRKKTEDSSSGKS | 1896 | Q14966 | |
| KRKKSKGDSDISDEE | 1006 | Q5T200 | |
| VQKDSSKTAKGKDAS | 1741 | E9PAV3 | |
| SRSTKAVSEKKAKGL | 226 | P25189 |